Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study.

Marcelo Maia Pinheiro,Felipe Moura Maia Pinheiro, Marcelo Müller de Arruda, Geane Moron Beato, Graciele Alves Corrêa Lima Verde, Georgiana Bianchini,Pedro Rosário Moraes Casalenuovo, Aline Aparecida Agostini Argolo,Lucilene Telles de Souza, Flávia Gomes Pessoa, Thiago Santos Hirose,Eduardo Filgueiras Senra,Camillo Ricordi,Andrea Fabbri,Marco Infante,Susana Nogueira Diniz

Archives of endocrinology and metabolism（2023）

引用 2|浏览7

暂无评分

摘要

Therapy with VIDPP-4i was associated with a higher frequency and duration of the honeymoon phase. Randomized controlled trials are needed to confirm these findings.

查看译文

关键词

vitamin d3,diabetes,sitagliptin,clinical remission,new-onset,case-control

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要